NCT03403634 2022-03-02
Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver
Roswell Park Cancer Institute
Phase 2 Completed
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)